Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP937291.RA32LX9-R2DJlYWW6WjMDGFK_kE9lDNd1SyR4WSnDQ0r8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP937291.RA32LX9-R2DJlYWW6WjMDGFK_kE9lDNd1SyR4WSnDQ0r8130_assertion type Assertion NP937291.RA32LX9-R2DJlYWW6WjMDGFK_kE9lDNd1SyR4WSnDQ0r8130_head.
- NP937291.RA32LX9-R2DJlYWW6WjMDGFK_kE9lDNd1SyR4WSnDQ0r8130_assertion description "[The in vitro analyses of five ovarian cancer cell lines demonstrated that cells with low MAD2 expression were less sensitive to paclitaxel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP937291.RA32LX9-R2DJlYWW6WjMDGFK_kE9lDNd1SyR4WSnDQ0r8130_provenance.
- NP937291.RA32LX9-R2DJlYWW6WjMDGFK_kE9lDNd1SyR4WSnDQ0r8130_assertion evidence source_evidence_literature NP937291.RA32LX9-R2DJlYWW6WjMDGFK_kE9lDNd1SyR4WSnDQ0r8130_provenance.
- NP937291.RA32LX9-R2DJlYWW6WjMDGFK_kE9lDNd1SyR4WSnDQ0r8130_assertion SIO_000772 22069160 NP937291.RA32LX9-R2DJlYWW6WjMDGFK_kE9lDNd1SyR4WSnDQ0r8130_provenance.
- NP937291.RA32LX9-R2DJlYWW6WjMDGFK_kE9lDNd1SyR4WSnDQ0r8130_assertion wasDerivedFrom befree-2016 NP937291.RA32LX9-R2DJlYWW6WjMDGFK_kE9lDNd1SyR4WSnDQ0r8130_provenance.
- NP937291.RA32LX9-R2DJlYWW6WjMDGFK_kE9lDNd1SyR4WSnDQ0r8130_assertion wasGeneratedBy ECO_0000203 NP937291.RA32LX9-R2DJlYWW6WjMDGFK_kE9lDNd1SyR4WSnDQ0r8130_provenance.